Advancis Changes Name to MiddleBrook Pharmaceuticals, Inc
The Germantown pharmaceutical company will still focus on developing and commercializing anti-infective products but it needed to take a new identity to settle a dispute over its original name with European drug maker sanofi-aventis.
The company said it will change its NASDAQ trading symbol to MBRK, effective with the start of trading on June 29.
Please email us to report offensive comments.
The comments to this entry are closed.